BiotechTube

LPCN 1154A + Placebo

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Depression, Postpartum

Conditions

Depression, Postpartum, Depression, Post-Partum, Postpartum Depression (PPD), Post-Natal Depression, Peripartum Depression, Postnatal Depression

Trial Timeline

Jun 16, 2025 → Feb 17, 2026

NCT ID
NCT06979544

About LPCN 1154A + Placebo

LPCN 1154A + Placebo is a phase 3 stage product being developed by Lipocine for Depression, Postpartum. The current trial status is completed. This product is registered under clinical trial identifier NCT06979544. Target conditions include Depression, Postpartum, Depression, Post-Partum, Postpartum Depression (PPD).

What happened to similar drugs?

20 of 20 similar drugs in Depression, Postpartum were approved

Approved (20) Terminated (2) Active (0)
✅DuloxetineEli LillyApproved
✅duloxetineEli LillyApproved
✅DuloxetineEli LillyApproved
✅DuloxetineEli LillyApproved
✅Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)Eli LillyApproved
✅DuloxetineEli LillyApproved
✅duloxetine + fluoxetine + citalopram + paroxetine + sertralineEli LillyApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
5
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06979544Phase 3Completed

Competing Products

20 competing products in Depression, Postpartum

See all competitors
ProductCompanyStageHype Score
Olanzapine and Fluoxetine combination (OFC) + FluoxetineEli LillyPhase 3
40
DuloxetineEli LillyApproved
35
FK949EAstellas PharmaPhase 3
40
QuetiapineAstellas PharmaPre-clinical
26
duloxetine + escitalopram + placeboEli LillyPhase 3
40
duloxetineEli LillyApproved
43
Duloxetine HydrochlorideEli LillyPhase 3
40
DuloxetineEli LillyApproved
43
DuloxetineEli LillyApproved
43
Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)Eli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyApproved
43
duloxetine + fluoxetine + citalopram + paroxetine + sertralineEli LillyApproved
43
Olanzapine + PlaceboEli LillyPhase 3
40
Olanzapine + Fluoxetine + PlaceboEli LillyPhase 3
32
duloxetine + duloxetineEli LillyPre-clinical
26
olanzapine + ziprasidoneEli LillyApproved
43
Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved
43
Drug treatment with CymbaltaEli LillyApproved
39
DuloxetineEli LillyApproved
43